Page 1 of Clinical Trials for Hackensack University Medical Center [SPONSOR-COLLABORATORS], 24 Total Matches
- 1RecruitingLast Updated: October 14, 2011Condition(s): Multiple Myeloma
- 2CompletedLast Updated: October 27, 2011Condition(s): Immune Response to Influenza Vaccination
- 3RecruitingLast Updated: October 18, 2011Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome
- 4RecruitingLast Updated: November 15, 2010Condition(s): Multiple Myeloma; Auto Stem Cell Transplant
- 5RecruitingLast Updated: April 3, 2007Condition(s): Pediatric Cancer
- 6Active, not recruitingLast Updated: September 10, 2007Condition(s): Asystole; Bradycardia; Hypotension
- 7RecruitingLast Updated: June 3, 2011Condition(s): Myeloid Malignancies; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndrome
- 8RecruitingLast Updated: March 15, 2007Condition(s): Patient Discharge
- 9CompletedLast Updated: October 13, 2011Condition(s): Multiple Myeloma
- 10RecruitingLast Updated: November 15, 2010Condition(s): Diffuse Large B-cell Lymphoma.
- 11RecruitingLast Updated: October 14, 2011Condition(s): Graft Versus Host Disease
- 12Not yet recruitingLast Updated: October 31, 2011Condition(s): Transfusion Reactions; Post Cardiac Surgery
- 13CompletedLast Updated: October 21, 2008Condition(s): COPD; Sleep Disorders
- 14RecruitingLast Updated: October 16, 2007Condition(s): Melanoma (Skin)
- 15RecruitingLast Updated: December 22, 2011Condition(s): Multiple Myeloma
- 16RecruitingLast Updated: October 13, 2011Condition(s): Multiple Myeloma
- 17CompletedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaLast Updated: October 13, 2011Condition(s): Multiple Myeloma
- 18RecruitingLast Updated: May 30, 2007Condition(s): Breast Cancer
- 19RecruitingLast Updated: December 28, 2011Condition(s): Multiple Myeloma
- 20RecruitingLast Updated: November 15, 2010Condition(s): Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Hackensack+University+Medical+Center
